Interclean Shanghai

Supurva Healthcare Group enters into agreement with MelMedtronics for expanding into Audiology Secto

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Supurva Healthcare Group, Inc. (also known as Lighthouse Petroleum, Inc.) (“Supurva”) (PINKSHEETS:LHPT), today announces it has entered into an exclusive licensing agreement with MelMedtronics, Inc. (“MelMedtronics”), a revolutionary medical device company specializing in disorders of hearing and tinnitus. Under the licensing agreement, Supurva is granted, effective immediately, exclusive rights to sell their proprietary hearing devices to customers in the Greater Houston Metropolitan Area. The audiology sector is expected to have very strong growth in the next ten years as the baby boomer generation continues to age.
MelMedtronics currently has several audiology products (one device, The Inhibitor(TM) and eight iPad applications, iA Audiometers(TM) (8 models), Tinnitus Adaptation Program (TAP(TM) ) and a new generation of treatment devices; Tinnitus Neuromodulation Treatment (TNT(R)), iA-PSAD (Personal Sound Amplification Device) and iA-HA (hearing aid) are also in development. The company’s iA-TEP(TM) application and iA Audiometers(TM) applications are iOS based and are used by Audiologists, ENT’s, Hearing Instrument Specialists, Primary Care Physicians, Pediatricians and Public Schools to evaluate their patients who have tinnitus (CPT-92625) and/or hearing loss (CPT-92577).
MelMedrotronics has also developed a Tele-Audiology system that uses iOS devices (iPads and/or iPhones) to evaluate patients anywhere in the world, which will greatly reduce the cost of evaluation and treatment for hearing impaired individuals world-wide.
Gerard Danos, Chairman and CEO of Supurva stated, “Management believes this new venture in audiology has even greater opportunity in the long term care sector than the company’s expanding dental business and will soon become one of the cornerstone businesses of Supurva Healthcare Group. In addition, the entry into this sector produces obvious synergies between our other businesses as most of our existing clients are also candidates for MelMedtrontonics’ audiology products.”

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »